Roy D. Baynes insider trades
Open-market stock purchases and sales by Roy D. Baynes, Unknown at Aardvark Therapeutics, Inc, from SEC Form 4 filings since Jul 19, 2016.
Recent trades
| Date | Stock | Trade | Value |
|---|---|---|---|
| Aug 14, 2026 | AARD Aardvark Therapeutics, Inc | Bought (not open market) | — |
| Jun 26, 2026 | NTRA Natera, Inc | Bought (not open market) | — |
| Jun 26, 2026 | NTRA Natera, Inc | Bought (not open market) | — |
| Jun 12, 2026 | TVTX Travere Therapeutics, Inc | Sold | $225K |
| Jun 12, 2026 | TVTX Travere Therapeutics, Inc | Bought (not open market) | — |
| May 19, 2026 | TVTX Travere Therapeutics, Inc | Bought (not open market) | — |
| May 19, 2026 | TVTX Travere Therapeutics, Inc | Bought (not open market) | — |
| May 15, 2026 | NRIX Nurix Therapeutics, Inc | Bought (not open market) | — |
| May 5, 2026 | TVTX Travere Therapeutics, Inc | Sold | $210K |
| May 5, 2026 | TVTX Travere Therapeutics, Inc | Bought (not open market) | — |
| May 1, 2026 | TVTX Travere Therapeutics, Inc | Sold | $431K |
| May 1, 2026 | TVTX Travere Therapeutics, Inc | Bought (not open market) | — |
| Apr 24, 2026 | NTRA Natera, Inc | Bought (not open market) | — |
| Apr 14, 2026 | TVTX Travere Therapeutics, Inc | Sold | $1.1M |
| Apr 14, 2026 | TVTX Travere Therapeutics, Inc | Sold | $284K |
| Apr 14, 2026 | TVTX Travere Therapeutics, Inc | Bought (not open market) | — |
| Apr 14, 2026 | TVTX Travere Therapeutics, Inc | Bought (not open market) | — |
| Apr 14, 2026 | TVTX Travere Therapeutics, Inc | Bought (not open market) | — |
| Apr 14, 2026 | TVTX Travere Therapeutics, Inc | Bought (not open market) | — |
| Apr 6, 2026 | TVTX Travere Therapeutics, Inc | Sold | $330K |
| Apr 6, 2026 | TVTX Travere Therapeutics, Inc | Bought (not open market) | — |
| Mar 2, 2026 | EIKN Eikon Therapeutics, Inc | Bought (not open market) | — |
| Jan 30, 2026 | NTRA Natera, Inc | Bought (not open market) | — |
| Nov 20, 2025 | NTRA Natera, Inc | Sold | $401K |
| Nov 20, 2025 | NTRA Natera, Inc | Sold | $425K |
Companies traded
- AARD Aardvark Therapeutics, Inc: other filings, last Aug 14, 2026
- NTRA Natera, Inc: 15 sales, last Jun 26, 2026
- TVTX Travere Therapeutics, Inc: 8 sales, last Jun 12, 2026
- NRIX Nurix Therapeutics, Inc: other filings, last May 15, 2026
- EIKN Eikon Therapeutics, Inc: other filings, last Mar 2, 2026
- ATRA Atara Biotherapeutics, Inc: other filings, last Jun 23, 2022
- RTRX Retrophin, Inc: other filings, last May 15, 2020